Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 3: Orally active anti-inflammatory agents
- 19 July 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (15) , 4019-4022
- https://doi.org/10.1016/j.bmcl.2004.05.041
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 2: Improvement of in vitro activityBioorganic & Medicinal Chemistry Letters, 2004
- Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1Bioorganic & Medicinal Chemistry Letters, 2003
- The IKK/NF-κB pathwayCritical Care Medicine, 2002
- Involvement of NF‐κB in the regulation of cyclooxygenase‐2 protein expression in LPS‐stimulated J774 macrophagesFEBS Letters, 1997
- IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIKScience, 1997
- IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB ActivationScience, 1997
- The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB ActivationPublished by Elsevier ,1997
- Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.Inflammation, 1997
- Nuclear Factor kB Is Activated by Arachidonic Acid but Not by Eicosapentaenoic AcidBiochemical and Biophysical Research Communications, 1996